MediXall Group, Inc.
MDXL · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -26.5% | -55.3% | 25% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 57.4% | 72.4% | 57.3% | 48.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -771.4% | -717.5% | -258.2% | -1,036.1% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 678.9% | -919.5% | -411.9% | -1,539.2% |
| EPS Diluted | 0.001 | -0.004 | -4.2 | -0.012 |
| % Growth | 134.1% | 99.9% | -35,493.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |